JP2020122016A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020122016A5 JP2020122016A5 JP2020086709A JP2020086709A JP2020122016A5 JP 2020122016 A5 JP2020122016 A5 JP 2020122016A5 JP 2020086709 A JP2020086709 A JP 2020086709A JP 2020086709 A JP2020086709 A JP 2020086709A JP 2020122016 A5 JP2020122016 A5 JP 2020122016A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- cycloalkyl
- compound
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims description 46
- 150000001875 compounds Chemical class 0.000 claims description 45
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 27
- 229910052799 carbon Inorganic materials 0.000 claims description 26
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 22
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 22
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 22
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 21
- 229910052760 oxygen Inorganic materials 0.000 claims description 20
- 229910052717 sulfur Inorganic materials 0.000 claims description 20
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 12
- 239000012453 solvate Substances 0.000 claims description 12
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 11
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 claims description 11
- 150000003852 triazoles Chemical class 0.000 claims description 11
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 8
- QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims description 3
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000002924 anti-infective effect Effects 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 229930192474 thiophene Natural products 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 description 18
- 125000003118 aryl group Chemical group 0.000 description 12
- 125000005843 halogen group Chemical group 0.000 description 10
- 125000000623 heterocyclic group Chemical group 0.000 description 10
- 0 CCCCCCCNc(c(C)c1)c(C=*)cc1N(CC(C*)O1)C1=O Chemical compound CCCCCCCNc(c(C)c1)c(C=*)cc1N(CC(C*)O1)C1=O 0.000 description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- -1 C 1 to C 6 alkoxy Chemical group 0.000 description 6
- 238000000034 method Methods 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021143166A JP2021183647A (ja) | 2015-07-17 | 2021-09-02 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2023127905A JP7585405B2 (ja) | 2015-07-17 | 2023-08-04 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2024140841A JP2024152930A (ja) | 2015-07-17 | 2024-08-22 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562193963P | 2015-07-17 | 2015-07-17 | |
| US62/193,963 | 2015-07-17 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521488A Division JP6786598B2 (ja) | 2015-07-17 | 2016-07-15 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021143166A Division JP2021183647A (ja) | 2015-07-17 | 2021-09-02 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020122016A JP2020122016A (ja) | 2020-08-13 |
| JP2020122016A5 true JP2020122016A5 (cg-RX-API-DMAC7.html) | 2021-10-14 |
| JP7232212B2 JP7232212B2 (ja) | 2023-03-02 |
Family
ID=57834866
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521488A Active JP6786598B2 (ja) | 2015-07-17 | 2016-07-15 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2020086709A Active JP7232212B2 (ja) | 2015-07-17 | 2020-05-18 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2021143166A Withdrawn JP2021183647A (ja) | 2015-07-17 | 2021-09-02 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2023127905A Active JP7585405B2 (ja) | 2015-07-17 | 2023-08-04 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2024140841A Pending JP2024152930A (ja) | 2015-07-17 | 2024-08-22 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018521488A Active JP6786598B2 (ja) | 2015-07-17 | 2016-07-15 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021143166A Withdrawn JP2021183647A (ja) | 2015-07-17 | 2021-09-02 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2023127905A Active JP7585405B2 (ja) | 2015-07-17 | 2023-08-04 | 抗微生物治療のための置換フェニルオキサゾリジノン |
| JP2024140841A Pending JP2024152930A (ja) | 2015-07-17 | 2024-08-22 | 抗微生物治療のための置換フェニルオキサゾリジノン |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10550092B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3932917A3 (cg-RX-API-DMAC7.html) |
| JP (5) | JP6786598B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102511898B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN113603683B (cg-RX-API-DMAC7.html) |
| AU (3) | AU2016295165B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018000991A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2990260A1 (cg-RX-API-DMAC7.html) |
| EA (2) | EA037643B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2897973T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017015106A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201800189B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016295165B2 (en) * | 2015-07-17 | 2021-04-22 | The Global Alliance For Tb Drug Development, Inc. | Substituted phenyloxazolidinones for antimicrobial therapy |
| WO2017066964A1 (en) * | 2015-10-22 | 2017-04-27 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| CN108727406B (zh) * | 2017-03-28 | 2021-12-07 | 北京协和制药二厂 | 含氮杂环取代的苯并噁嗪噁唑烷酮类化合物及其制备方法和用途 |
| KR102777328B1 (ko) | 2018-07-25 | 2025-03-10 | 자이두스 라이프사이언시즈 리미티드 | 포유류 감염 치료를 위한 신규 화합물 |
| WO2020147504A1 (en) * | 2019-01-18 | 2020-07-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compounds and methods of use thereof as antibacterial agents |
| WO2020234636A1 (en) | 2019-05-17 | 2020-11-26 | Cadila Healthcare Limited | Novel compounds for the treatment of mammalian infections |
| CN110922411B (zh) * | 2019-11-27 | 2021-06-04 | 合肥远志医药科技开发有限公司 | 一种药物中间体的合成方法 |
| WO2021184339A1 (en) * | 2020-03-20 | 2021-09-23 | Merck Sharp & Dohme Corp. | Oxazolidinone compound and methods of use thereof as an antibacterial agent |
| CN113999152B (zh) * | 2021-07-14 | 2023-05-09 | 上海凌富药物研究有限公司 | 一种顺式-1-苄基-2,4-二烷氧基羰基氮杂环丁烷的合成方法 |
| EP4568961A1 (en) * | 2022-08-10 | 2025-06-18 | Merck Sharp & Dohme LLC | Processes for preparing oxazolidinone compounds |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115155A (en) * | 1993-09-09 | 2003-04-30 | Upjohn Co | Substituted oxazine and thiazine oxazolidinone antimicrobials. |
| PT792273E (pt) | 1994-11-15 | 2003-06-30 | Upjohn Co | Produtos antibacterianos de oxazolidinona substituida com oxazina e tiazina biciclicas |
| CN1068328C (zh) * | 1995-05-11 | 2001-07-11 | 法玛西雅厄普约翰美国公司 | 螺环和双环二嗪基和咔嗪基噁唑烷酮类 |
| US6255304B1 (en) * | 1997-05-30 | 2001-07-03 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| WO2000032599A1 (en) * | 1998-11-27 | 2000-06-08 | Pharmacia & Upjohn Company | Oxazolidinone antibacterial agents having a thiocarbonyl functionality |
| EP1451164A2 (en) * | 2001-07-12 | 2004-09-01 | PHARMACIA & UPJOHN COMPANY | Amide derivatives having improved solubility |
| CN1649866A (zh) | 2002-02-28 | 2005-08-03 | 阿斯特拉曾尼卡有限公司 | 3－环状基－5－(含氮5－元环)甲基－噁唑烷酮衍生物及其作为抗菌药物的用途 |
| AU2003224345A1 (en) * | 2002-04-30 | 2003-11-17 | Orchid Chemicals & Pharmaceuticals | Antibacterial agents |
| TW200403240A (en) * | 2002-06-28 | 2004-03-01 | Upjohn Co | Difluorothioacetamides of oxazolidinones as antibacterial agents |
| US6875784B2 (en) * | 2002-10-09 | 2005-04-05 | Pharmacia & Upjohn Company | Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives |
| CN1237056C (zh) * | 2002-12-25 | 2006-01-18 | 中国科学院上海药物研究所 | 噁唑烷酮类化合物、其制备方法和用途 |
| JP2007503426A (ja) * | 2003-08-25 | 2007-02-22 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 新規な抗微生物性アリールオキサゾリジノン化合物 |
| US20090137553A1 (en) | 2004-11-29 | 2009-05-28 | Pharmacia And Upjohn Company Llc | Thiazepine Oxazolidinones as Antibacterial Agents |
| WO2006121962A1 (en) * | 2005-05-06 | 2006-11-16 | University Of South Florida | N-thiolated 2-oxazolidone antibiotics |
| WO2007000644A1 (en) * | 2005-06-29 | 2007-01-04 | Pharmacia & Upjohn Company Llc | Homomorpholine oxazolidinones as antibacterial agents |
| WO2007004037A1 (en) * | 2005-07-06 | 2007-01-11 | Pharmacia & Upjohn Company Llc | Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| AU2009228293B2 (en) | 2008-03-26 | 2012-11-08 | Tennor Therapeutics (Suzhou) Limited | Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones |
| KR100980681B1 (ko) | 2008-09-16 | 2010-09-07 | 한국과학기술연구원 | 디플루오로페닐 유도체를 갖는 신규한 옥사졸리디논 유도체또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 하는 항생제 조성물 |
| US20110053916A1 (en) * | 2009-08-14 | 2011-03-03 | Vertex Pharmaceuticals Incorporated | Pyrimidine compounds as tuberculosis inhibitors |
| AU2016295165B2 (en) * | 2015-07-17 | 2021-04-22 | The Global Alliance For Tb Drug Development, Inc. | Substituted phenyloxazolidinones for antimicrobial therapy |
| JP2023127905A (ja) * | 2022-03-02 | 2023-09-14 | パナソニックＩｐマネジメント株式会社 | 物品管理システム、物品管理方法及びプログラム |
-
2016
- 2016-07-15 AU AU2016295165A patent/AU2016295165B2/en active Active
- 2016-07-15 JP JP2018521488A patent/JP6786598B2/ja active Active
- 2016-07-15 CA CA2990260A patent/CA2990260A1/en active Pending
- 2016-07-15 US US15/738,503 patent/US10550092B2/en active Active
- 2016-07-15 EP EP21185896.4A patent/EP3932917A3/en active Pending
- 2016-07-15 WO PCT/US2016/042486 patent/WO2017015106A1/en not_active Ceased
- 2016-07-15 EA EA201792566A patent/EA037643B1/ru unknown
- 2016-07-15 KR KR1020187003093A patent/KR102511898B1/ko active Active
- 2016-07-15 CN CN202111073361.5A patent/CN113603683B/zh active Active
- 2016-07-15 CN CN201680054227.1A patent/CN108348507B/zh active Active
- 2016-07-15 EP EP16828300.0A patent/EP3307268B1/en active Active
- 2016-07-15 EA EA202190167A patent/EA202190167A1/ru unknown
- 2016-07-15 BR BR112018000991A patent/BR112018000991A2/pt not_active Application Discontinuation
- 2016-07-15 ES ES16828300T patent/ES2897973T3/es active Active
-
2018
- 2018-01-10 ZA ZA2018/00189A patent/ZA201800189B/en unknown
-
2020
- 2020-01-13 US US16/740,660 patent/US11964949B2/en active Active
- 2020-05-18 JP JP2020086709A patent/JP7232212B2/ja active Active
-
2021
- 2021-07-16 AU AU2021205116A patent/AU2021205116B2/en active Active
- 2021-09-02 JP JP2021143166A patent/JP2021183647A/ja not_active Withdrawn
-
2022
- 2022-11-11 AU AU2022268387A patent/AU2022268387A1/en not_active Abandoned
-
2023
- 2023-08-04 JP JP2023127905A patent/JP7585405B2/ja active Active
-
2024
- 2024-08-22 JP JP2024140841A patent/JP2024152930A/ja active Pending